US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of “engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
The FTC report said the companies responsible for controlling spending on drugs were sometimes steering patients toward more ...
Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the ...
The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit ...
U.S. equities were higher around midday as August retail sales were higher than anticipated and the Fed began its two-day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback